| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.614 | 0.004 | 0.614 | Insulin secretagoues | 0.606 0.004 DBMET01326 0.601 0.004 DBMET01327 | ||
| 0.603 | 0.008 | 0.635 | Hypoglycemic | 0.635 0.006 DBMET01326 0.611 0.007 DBMET01327 | DBMET01326 | |
| 0.397 | 0.029 | 0.407 | Cardiotonic | 0.375 0.033 DBMET01326 0.407 0.028 DBMET01327 | DBMET01327 | |
| 0.387 | 0.103 | 0.387 | Beta lactamase inhibitor | 0.336 0.12 DBMET01327 | ||
| 0.38 | 0.102 | 0.503 | Cyclophilin D inhibitor | 0.503 0.049 DBMET01326 0.48 0.056 DBMET01327 | DBMET01326 | |
| 0.205 | 0.004 | 0.205 | Potassium channel (ATP-sensitive) blocker | 0.163 0.004 DBMET01326 0.121 0.009 DBMET01327 | ||
| 0.246 | 0.074 | 0.31 | Platelet antagonist | 0.256 0.07 DBMET01326 0.31 0.05 DBMET01327 | DBMET01327 | |
| 0.124 | 0.006 | 0.124 | Bombesin 3 receptor antagonist | 0.115 0.008 DBMET01326 0.116 0.008 DBMET01327 | ||
| 0.13 | 0.014 | 0.13 | Lipase inhibitor | 0.117 0.019 DBMET01326 0.107 0.024 DBMET01327 | ||
| 0.105 | 0.006 | 0.166 | Potassium channel (Inward rectifier) blocker | 0.166 0.004 DBMET01326 0.056 0.027 DBMET01327 | DBMET01326 | |
| 0.102 | 0.01 | 0.102 | CC chemokine 3 receptor antagonist | 0.083 0.013 DBMET01326 0.061 0.019 DBMET01327 | ||
| 0.161 | 0.071 | 0.169 | Anticoagulant | 0.147 0.083 DBMET01326 0.169 0.066 DBMET01327 | DBMET01327 | |
| 0.09 | 0.005 | 0.09 | Carbonic anhydrase I stimulant | 0.08 0.007 DBMET01326 0.087 0.006 DBMET01327 | ||
| 0.086 | 0.008 | 0.086 | Carbonic anhydrase II stimulant | 0.079 0.01 DBMET01326 0.083 0.008 DBMET01327 | ||
| 0.204 | 0.127 | 0.204 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.1 | 0.025 | 0.1 | Thrombin inhibitor | 0.089 0.033 DBMET01326 0.088 0.034 DBMET01327 | ||
| 0.096 | 0.03 | 0.096 | Cannabinoid receptor antagonist | 0.063 0.059 DBMET01326 | ||
| 0.17 | 0.115 | 0.17 | Potassium channel blocker | 0.143 0.142 DBMET01326 | ||
| 0.088 | 0.035 | 0.088 | Epoxide hydrolase inhibitor | 0.073 0.049 DBMET01326 0.08 0.042 DBMET01327 | ||
| 0.042 | 0.008 | 0.042 | Epoxide hydrolase 2 inhibitor | 0.03 0.014 DBMET01326 0.032 0.013 DBMET01327 | ||
| 0.098 | 0.065 | 0.103 | Chemokine receptor antagonist | 0.103 0.06 DBMET01327 | DBMET01327 | |
| 0.064 | 0.036 | 0.072 | Carbonic anhydrase stimulant | 0.052 0.051 DBMET01326 0.072 0.03 DBMET01327 | DBMET01327 | |
| 0.062 | 0.041 | 0.062 | Cannabinoid CB1 receptor agonist | |||
| 0.051 | 0.031 | 0.051 | Collagenase inhibitor | 0.047 0.038 DBMET01326 0.051 0.03 DBMET01327 | ||
| 0.056 | 0.04 | 0.073 | Beta 1 adrenoreceptor antagonist | 0.073 0.023 DBMET01326 0.051 0.045 DBMET01327 | DBMET01326 | |
| 0.058 | 0.045 | 0.058 | Bcl-xL inhibitor | 0.057 0.051 DBMET01326 0.058 0.046 DBMET01327 | ||
| 0.018 | 0.008 | 0.018 | Carbonic anhydrase IV stimulant | 0.016 0.01 DBMET01326 0.018 0.008 DBMET01327 | ||
| 0.058 | 0.047 | 0.058 | Cannabinoid CB1 receptor antagonist | |||
| 0.016 | 0.008 | 0.016 | CC chemokine 10 receptor antagonist | |||
| 0.042 | 0.034 | 0.051 | Purinergic P2Y antagonist | 0.046 0.03 DBMET01326 0.051 0.025 DBMET01327 | DBMET01327 | |
| 0.037 | 0.029 | 0.037 | Potassium channel Kv1.1 blocker | |||
| 0.07 | 0.064 | 0.083 | Somatostatin 1 agonist | 0.083 0.048 DBMET01326 0.079 0.052 DBMET01327 | DBMET01326 | |
| 0.044 | 0.043 | 0.044 | Matrix metalloproteinase 1 inhibitor | |||
| 0.027 | 0.029 | 0.054 | CXC chemokine 3 receptor antagonist | 0.054 0.008 DBMET01327 | DBMET01327 | |
| 0.056 | 0.061 | 0.057 | Trypsin inhibitor | 0.057 0.056 DBMET01327 | DBMET01327 | |
| 0.017 | 0.03 | 0.025 | Beta 1 adrenoreceptor agonist | 0.025 0.012 DBMET01326 0.023 0.014 DBMET01327 | DBMET01326 | |
| 0.035 | 0.058 | 0.067 | Prostaglandin E2 antagonist | 0.049 0.036 DBMET01326 0.067 0.025 DBMET01327 | DBMET01327 | |
| 0.061 | 0.084 | 0.077 | Metalloproteinase-2 inhibitor | 0.077 0.055 DBMET01327 | DBMET01327 | |
| 0.036 | 0.06 | 0.046 | Beta 2 adrenoreceptor antagonist | 0.046 0.042 DBMET01326 | DBMET01326 | |
| 0.176 | 0.211 | 0.262 | Antithrombotic | 0.211 0.165 DBMET01326 0.262 0.117 DBMET01327 | DBMET01327 | |
| 0.049 | 0.093 | 0.072 | CXC chemokine receptor antagonist | 0.072 0.047 DBMET01327 | DBMET01327 | |
| 0.037 | 0.082 | 0.045 | Beta adrenoreceptor agonist | 0.045 0.031 DBMET01326 | DBMET01326 | |
| 0.043 | 0.098 | 0.061 | Beta adrenoreceptor antagonist | 0.061 0.053 DBMET01326 | DBMET01326 | |
| 0.024 | 0.092 | 0.047 | Prostaglandin antagonist | 0.047 0.042 DBMET01327 | DBMET01327 | |
| 0.05 | 0.122 | 0.059 | Prolactin release inhibitor | 0.059 0.056 DBMET01326 | DBMET01326 | |
| 0.02 | 0.104 | 0.056 | Thromboxane A2 antagonist | 0.056 0.031 DBMET01327 | DBMET01327 | |
| 0.047 | 0.132 | 0.082 | Adrenaline agonist | 0.082 0.055 DBMET01326 | DBMET01326 | |
| 0.218 | 0.308 | 0.305 | Antiinflammatory | 0.294 0.221 DBMET01326 0.305 0.21 DBMET01327 | DBMET01327 | |
| 0.157 | 0.255 | 0.222 | Sodium/bile acid cotransporter inhibitor | 0.222 0.159 DBMET01327 | DBMET01327 | |
| 0.021 | 0.127 | 0.051 | Thromboxane antagonist | 0.051 0.04 DBMET01327 | DBMET01327 | |
| 0.045 | 0.155 | 0.059 | Beta 2 adrenoreceptor agonist | 0.059 0.056 DBMET01326 | DBMET01326 | |
| 0.009 | 0.138 | 0.025 | Prostaglandin EP4 antagonist | 0.025 0.019 DBMET01327 | DBMET01327 | |
| 0.072 | 0.222 | 0.163 | Diuretic | 0.163 0.067 DBMET01327 | DBMET01327 | |
| 0.041 | 0.233 | 0.071 | Cell adhesion molecule inhibitor | 0.071 0.068 DBMET01327 | DBMET01327 | |
| 0.013 | 0.303 | 0.043 | Neuraminidase (Influenza A) inhibitor | 0.043 0.037 DBMET01327 | DBMET01327 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |